₹ 2,236.01 Cr
1.99%
S&P BSE Healthcare TRI
INF769K01EA2
5000.0
1000.0
1000
Vrijesh Kasera
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
Mirae Asset Healthcare Fund -Regular Growth | 47.76 | 13.95 | 25.04 |
S&P BSE Healthcare TRI | 52.62 | 13.64 | 22.27 |
Equity
Debt
Others
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.83 |
Cipla Ltd. | 9.65 |
Aurobindo Pharma Ltd. | 9.28 |
Dr. Reddy's Laboratories Ltd. | 7.22 |
Apollo Hospitals Enterprise Ltd. | 6.02 |
Lupin Ltd. | 4.27 |
Krishna Institute of Medical Sciences Ltd | 4.17 |
Divi's Laboratories Ltd. | 4.09 |
JB Chemicals & Pharmaceuticals Ltd. | 4.02 |
Torrent Pharmaceuticals Ltd. | 3.89 |
Sector | Holdings (%) |
---|---|
Healthcare | 96.95 |
Financial | 1.36 |
Chemicals | 1.22 |
Others | 0.43 |
N/A | 0.03 |
Unclassified | 0.01 |
Scheme Name | 5Y (%) |
---|---|
Mirae Asset Healthcare Reg Gr | 25.04 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 25.77 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 23.56 |
SBI HEALTHCARE Opportunities Reg Gr | 24.87 |
Nippon India Pharma Fund Gr Gr | 24.41 |
UTI Healthcare Reg Gr | 22.44 |
DSP Healthcare Reg Gr | 27.19 |
LIC MF Healthcare Fund Reg Gr | 19.52 |
ITI Pharma and Healthcare Fund Reg Gr | 0.0 |